Our board of directors
P.Eng, B.Sc., I.E.
Director of Business Development, Stantec
Ben Lee brings over 25 years of experience in all aspects of Project Management. He has successfully delivered over $1B in major projects in the biotechnology, pharmaceutical, hospital and manufacturing sectors from concept to completion.
Mr. Lee has comprehensive knowledge and practice of current GMP, GLP, FDA and CFR 21 Part 11. He possesses direct and extensive experience in project planning such as benefit-cost analysis, life cycle costing, feasibility studies, change control, operational/technical requirements, analysis & optimization, functional/space programming, land use and environmental approvals. Mr. Lee has been invited to speak at several associations, including the ISPE conference as a keynote speaker.
President, Positive Regulatory Outcomes Ltd.
Kent has been in the Pharmaceutical Industry since 1990 working in Health Canada and later within the industry responsible to lead product development, regulatory affairs, business development, product registration and patent litigation. He was previously the Vice-President, Scientific Affairs-Canada and Latin at Actavis. Kent has been a member of the PSG Board of Directors since 2011, and is also a member of the Annual Conference Committee. Kent holds a B.Sc. in Microbiology from the University of Manitoba.
B. Comm. CPA/CA
Chief Financial Officer, Blue Goose Capital Corp.
Bob Hill is a business leader and a Chartered Accountant with 30 years of experience. He is currently Chief Financial Officer of Motion Specialties, Canada’s leading provider of complex rehab, respiratory and home accessibility solutions. Bob started his career with Price Waterhouse, was previously VP Finance at Biogen Idec and VP Finance at Sanofi Pasteur, and has also worked in senior positions for GSK, Nestle and Campbell Soup. Bob has a long track record of driving exceptional top and bottom line growth, acting as a strategic partner to the CEO. His strong business acumen gained through diverse experiences, including time as a sales executive, combined with his leadership skills create a winning formula.
Donna is a committed human resource leader with more than 20 years of progressive experience in multiple industries, including most recently the Head of Human Resources for Thereapure Bio Pharma. Her knowledge spans across all areas of human resources, championing the building or restructuring of the function in different countries. Donna believes in the importance of education and holds a business degree, a Bachelor of Arts in Labour Studies & Sociology, a Human Resources Management Certificate, and a CHRP, along with a few development courses related to human resources. In addition, she has been an instructor at Sheridan College. Along her career, Donna has been charged with restructuring complicated human resources functions in multiple locations simultaneously. As a member of the executive team, she has been responsible for developing initiatives in talent acquisition, training & development, succession planning, performance management, organizational restructuring, and competency models, amongst others, to ensure the HR function is in line with the business structure. Donna is a Board Member with BioTalent Canada and the PSG.
Director, Health Technology Assessment, Emerging Markets, Eli Lilly & Company
Manny Papadimitropoulos graduated in Pharmacy from the University of Saskatchewan and has worked in retail pharmacy, the pharmaceutical industry, and academia over the last 25 years. His pharmacy experience has been primarily in health economics, and clinical research. He has a master's in Pharmacy and a Ph.D. in Health Economic Evaluation from the University of Toronto in Canada. Manny is currently the Director of Health Technology Assessment – Emerging Markets at Eli Lilly and Company. He is also an adjunct assistant professor at the University of Toronto, Faculty of Pharmacy, in the Administrative/Social Pharmacy area. Manny’s areas of research are in HTA and decision analysis, and is a supervisor of four graduate students.
President, HEMS Consulting Inc.
John is a regulatory affairs professional with over 30 years experience in the Pharmaceutical Industry. After starting in the R&D and Bioanalytical Laboratories at Apotex, he held senior roles in regulatory affairs where he was responsible for the pre-market and post-market regulatory activities pertaining to generic products in Canada, US, EU, and other major markets. John has represented the generic industry on a number of Health Canada advisory committees (APETI, ACES, GERA) and Internationally as a member on ICH EWGs (M- ESTRI and M8-eCTD). John holds a B.Sc. in Biochemistry from McMaster University.
Senior Scientific Advisor. Chemistry, Health Canada
Graduating with an Hons. B.Sc. in Chemistry from the University of Toronto in 1982, Arvin has been involved in the pharmaceutical industry since 1983 working as a laboratory chemist in the private sector with the majority of his career being in the area of regulatory oversight of the pharmaceutical industry in Canada. Arvin joined Health Canada in 1989 after pursuing a Masters degree in Synthetic Organic Chemistry at Memorial University of Newfoundland. Arvin started his Government career as a Senior Evaluator in the Bureau of Pharmaceutical Surveillance reviewing generic drug submissions. Using this experience, Arvin held the position of Manager, Generic Drugs Quality Division (1996 – 2009) with the Bureau of Pharmaceutical Sciences and currently is Senior Scientific Advisor – Chemistry in the Director's Office within the same Bureau of Therapeutic Products Directorate of HPFB. Furthermore, he has been called upon to represent BPS in the legal arena and at the World Health Organization for a number of years as a Consultant for the Pre-Qualification of Drugs Programme which is responsible for providing approved generic drug products for Africa and Asia.
Deputy Director, Site Engineering, Sanofi Pasteur Limited
Chetan brings 20 years of experience in business transformation, engineering, and operations management, spanning across four continents in diverse industries, including composites, chemical manufacturing and bio-technology. He is the Head of Site Engineering at Sanofi Pasteur, and is responsible for leading the execution of multi-million dollar capital projects and providing leadership to the Technical Services organization. His previous employers include Honeywell, Owens Corning & Siemens, where he held various management and leadership positions. He holds a degree in Mechanical Engineering and an MBA from Rotman School of Management, University of Toronto.
B.Sc. Pharm. D.T.M.
President, Zipharm International Inc.
Max is a board member, Chairman of PSG Annual Conference Committee, and past Acting Executive Director of the PSG. As a pharmacist and entrepreneur, he is president and founder of Genpharm Inc., a major Toronto generic pharmaceutical company; part of an international group of pharma companies located in England, Ireland, Australia, New Zealand and Europe.
Max has been involved in substantial humanitarian activities, providing medicines and related humanitarian donations to third-world countries in Africa, Europe and Asia, valued at approximately $60 million. These included sizable contributions to Red Cross in North and South Vietnam for four consecutive years. Furthermore, Max visited/inspected Red Cross clinics, hospitals and humanitarian organizations in Vietnam. Max is also president and founder of Zipharm International Inc. Toronto, which provides specialized consulting services to the pharma industry relating to regulatory, government, and business affairs.
David McSweeney B.Sc, AIT is currently the Computer System Subject Matter Expert, for PharmEng Technology. David has over 20 years of experience in the pharmaceutical industry in various roles from Research, Vaccine Production, CSV Compliance and Project Management. Areas of specialization pertain specifically to computer system implementations for all types of CSV systems from simple Lab systems to Global Custom CRM / ERP systems. He is a mentor and collaborative leader, who leads by example, experience and a thorough knowledge of current IT / manufacturing practices. In addition, Mr. McSweeney is an instructor at NSU and AAPS for CSV. David is recognized for his high personal standards for performance and ensuring that all aspects of compliance and data integrity are captured during implementations.
Manager, Professional Development
Amanda is a highly motivated and outgoing professional with over 10 years of experience in both the Pharmaceutical and Event Coordinating Industries. In addition to being a Principal Planner for a successful business, she also has an extensive background in Microbiology and Quality Control. Her career highlights include starting her own event coordinating business as well as working her way up from a Microbiology Analyst to the Department Head of Microbiology for a large contract laboratory in Toronto. She is always looking for ways to develop her skills and has been involved in many committees along her career including being an active member of the Pharmaceutical Sciences Group as well as the Hiring Committee at Seneca College School of Biological Sciences and Applied Chemistry.